Swiss Light Source SLS

Excelsus invites pharma companies to explore for free the possibilities of synchrotron X-ray powder diffraction

The second annual Spring Pharmaceutical Synchrotron X-Ray Powder Diffraction (SPS-XRPD-2) Workshop, organized together with the 16th Pharmaceutical Powder...

More details More details

Shaping the future of modern drug discovery

Video interview with Professor Dr. Gebhard Schertler Pharmaceutical and biotechnological industries often depend on the information acquired through...

More details

Infrastructure and R&D solutions for biotech and pharmaceutical industries

The Swiss Light Source (SLS) at the Paul Scherrer Institute (PSI) and the free-electron laser (SwissFEL) provide beams of exceptional brightness and stability...

More details

Life Science basic research on the top level

The Paul Scherrer Institute (PSI) is Switzerland’s biggest research institute for natural and engineering sciences. It hosts most of the country’s...

More details

Pharmaceutical mixtures: Excelsus achieves an unprecedented level of detection

X-Ray Powder Diffraction (XRPD) is a powerful technique that exploits the interaction between X-rays and matter to study the structural and microstructural...

More details

The value of the absolute structure

The exact knowledge and understanding of a molecule’s structure underpin all the substantial progress in chemical, agrarian and pharmaceutical research....

More details

Crystallization at its best

The success of many R&D projects in the pharmaceutical, chemical or agro industries depends on the exact and complete knowledge of a sample. To deliver...

More details

leadXpro “unlocks” new targets for structure-based drug discovery

One of the most promising groups of drug targets is that of integral membrane proteins. They are responsible for communicating signals from the outside...

More details
Subscribe to Swiss Light Source SLS